Blog

For nearly a century, we have called it polycystic ovary syndrome, or PCOS. That name is now changing. In May 2026, an international consensus group formally renamed PCOS Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The change was published in The Lancet and reflects something clinicians and patients have recognized for years. This condition was never…

GLP-1 medications can improve weight loss and metabolic health, but emerging research suggests they may also influence dopamine, motivation, and reward pathways. Explore the science, patient experiences, and why vitality involves more than the number on a scale.

GLP-1 medications are changing the weight loss conversation. For many people, they are life-changing. The food noise quiets. Appetite shifts. Weight starts moving. Inflammation may come down. Energy may improve. Labs may begin to reflect something that looks like hope instead of defeat. And let’s be honest, for people who have spent years fighting their…